Skip to content

Clinical study on the safety and efficacy of modified Qibaisan in the treatment of melasma

Clinical study on the safety and efficacy of modified Qibaisan in the treatment of melasma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000783
Enrollment
Unknown
Registered
2024-12-11
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

melasma

Interventions

Test group:Modified Qibaisan wet compress applied to the affected area
Control group 1:Hydroquinone cream applied externally to the affected area
Control group 2:Qibaisan wet compress applied to the affected area

Sponsors

Jiangsu Provincial People's Hospital Suqian Hospita
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1: Patients who meet the diagnostic criteria for melasma in both traditional Chinese and Western medicine 2: Female patients aged between 18-60 years old 3: The patient agrees to sign an informed consent form voluntarily submits to randomized treatment and is able to complete treatment and follow-up as required 4: The patient did not receive any treatment related to this disease in the three months prior to enrollment

Exclusion criteria

Exclusion criteria: 1: Patients with pigmentation caused by other organic diseases 2: Patients who need to be exposed to sunlight for a long time during the treatment process due to various reasons 3: Pregnant or lactating women 4: Patients with other facial skin diseases severe organic lesions and mental illnesses

Design outcomes

Primary

MeasureTime frame
Score of main clinical symptoms of melasma in traditional Chinese medicine;

Secondary

MeasureTime frame
Scoring of the number and morphology of blood vessels in melasma skin;Quality of life score for patients with melasma;

Countries

China

Contacts

Public ContactJin Xin

Jiangsu Provincial People's Hospital Suqian Hospita

jinxin871211@163.com15951896676

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026